Allopathic Medicine; Relying on acyclovir since 1982
Two Harvard/USC physicians just asked a question that's been ignored for too long: why are we still treating herpes with the same drug we've been using since 1982?
This MedPage Today op-ed breaks down the real toll of HSV beyond just outbreaks. We're talking brain infections, neonatal deaths, a possible link to Alzheimer's, and a potential role in 1 in 3 new HIV cases globally. Yet NIH funding for new treatments and vaccines is being cut, and the stigma around herpes keeps millions suffering in silence.
Some key points from the piece:
• 2/3 of people under 50 have HSV-1; 1 in 8 have HSV-2
• No new treatment approved in over 40 years.
Worth a read; https://www.medpagetoday.com/opinion/second-opinions/117039
u/Chaxxa4 — 6 days ago